Clover Biopharmaceuticals News and Activities
Executives
View the org chart displaying its 21 main executives
Most searched biographies at Clover Biopharmaceuticals
- Joshua Liang, Chief Executive Officer
- Xiaobin Wu, Independent Non-executive Director
- Xiang Liao, Independent Non-executive Director
Popular executive movements at Clover Biopharmaceuticals
- Nicholas Jackson has joined the company as President, Global Research and Development and Alliances (posted on October 20 2025).
Create your alert
to follow the executive moves at Clover Biopharmaceuticals.
Pharmaceuticals
Clover Biopharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Corden Pharma has announced the acquisition of AmbioPharm (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Clover Biopharmaceuticals
- Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 3 Trial Evaluating SCB-2019 as a Heterologous COVID-19 Booster Following Prior Vaccination with Inactivated, mRNA or Viral Vector Vaccines | Clover Biopharmaceuticals, Ltd.
- Clover Provides Update on 2022 Corporate Milestones | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 1 Trial with SCB-2020S, a Potentially Broadly Protective Chimeric COVID-19 Vaccine Candidate | Clover Biopharmaceuticals, Ltd.
- Clover’s Bivalent COVID-19 Vaccine Candidate Demonstrates Broad Neutralization Against Omicron and Other Variants of Concern | Clover Biopharmaceuticals, Ltd.
- Clover Appoints LiongHo Chua as President of Greater China | Clover Biopharmaceuticals, Ltd.
- Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial - Clover Biopharmaceuticals
- Clover and CEPI Expand Partnership for COVID-19 Vaccine Candidate to Include Evaluation as a Booster - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Announces Offer Price and Allotment Results of the Global Offering - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate - Clover Biopharmaceuticals
- View more press releases Close
Social media about Clover Biopharmaceuticals
- Clover Biopharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Clover Biopharmaceuticals on LinkedIn, X (Twitter) & YouTube
